Introduction
Gene therapy for skin diseases is evolving rapidly and several methods for gene transfer into the skin have been reported. Several viral vector methods such as recombinant adeno-associated virus vectors, lentiviral vectors and hemagglutinating virus of Japan-liposome method have been reported. [1] [2] [3] Viral vectors are often effective from the point of view of gene transfer, but concerns about safety, scalability of production and cost effectiveness need to be overcome before their clinical use can be established. It is true that these methods have advantages; however, thus far, the advantages do not seem to outweigh the disadvantages. On the other hand, nonviral vector methods such as gene gun, 4 electroporation, [5] [6] [7] liposome 8 and naked gene transfer [9] [10] [11] have been also reported. Non-viral methods are safer and cost effective compared to viral methods. Electroporation has been reported to improve transfer efficiency and improve wound healing. Jet injection of a solution containing naked plasmid has also been reported to have high efficiency of gene transfer to the skin in rats. 11 In this study, we examined whether the spring-powered jet injector, Shima Jet, which was originally developed as a non-needle jet injector of insulin, is effective for gene transfer into the skin aiming a therapeutic approach to skin diseases in humans. Because the Shima Jet has been already used in humans, the potential of gene therapy to skin diseases using the Shima Jet seems to be high.
Several basic diseases such as diabetes, arteriosclerosis obliterans, thromboangiitis obliterans, varicosity, vasculitis and decubitis ulcer cause a defect in the epidermis and dermis, and result in incurable ulcers, the main reason for which is a decrease in peripheral circulation. Wound healing is a complex programmed sequence of cellular and molecular processes, including inflammation, cell migration, angiogenesis, provisional matrix synthesis, collagen deposition and re-epithelialization. 12 In spite of proper wound treatment, some acute ulcers evolve into chronic non-healing wounds that show a dermal defect, ischemia and tissue necrosis. The healing processes are regulated by a number of growth factors such as basic fibroblast growth factor, transforming growth factor-b, epidermal growth factor, keratinocyte growth factor, platelet-derived growth factor, vascular endothelial growth factor and hepatocyte growth factor (HGF). [13] [14] [15] Interestingly, several growth factors that accelerate wound healing have been identified. 12 Hepatocyte growth factor was first found to be a potent mitogen for mature hepatocytes after purification and cloning. 16, 17 In terms of wound healing, HGF enhances the migration, cell growth and DNA synthesis of keratinocytes and result in wound closure. 18, 19 Hepatocyte growth factor also stimulates vascular endothelial cell migration, proliferation and organization into capillary-like tubes, leading to the promotion of angiogenesis. 20, 21 On the other hand, prostacyclin (PGI 2 ) is a metabolite of arachidonic acid, which inhibits platelet aggregation and smooth muscle cell proliferation and induces vasodilatation. Prostacyclin is widely used orally to treat human patients with peripheral arterial disease or ischemic wounds. Prostacyclin synthase (PGIS) catalyzes the conversion of prostaglandin H 2 to PGI 2 . In 1994, the amino-acid sequence of human PGIS was cloned. 22 Overexpression of the PGIS gene inhibits growth of vascular smooth muscle cells (VSMC), and transfer of PGIS gene ameliorates pulmonary hypertension and prevents neointimal formation after carotid balloon injury in rats. [23] [24] [25] Co-transfer of HGF and PGIS genes in a murine ischemic limb model has been reported to increase the concentration of HGF protein and resulted in a significant increase in blood flow and capillary density compared with transfer of HGF gene alone. 26, 27 Based on these results, we examined the effects of co-transfer of HGF and PGIS genes by the Shima Jet on wound healing in this study.
Results

Histological analysis of b-galactosidase expression
Initially, we examined the potential of the Shima Jet to transfer genes into the skin using reporter genes, because there has been no report showing the successful gene transfer achieved by the Shima Jet into the skin. Microscopic expression of b-galactosidase could be observed in the epidermal layer of the rat skin at 48 h after transfer by the Shima Jet (Figure 1a and b) .
However, in control sections, in which the control plasmid was injected, no expression of b-galactosidase could be observed (Figure 1c and d) .
Comparison of gene transfer efficiency into rat skin
So far, many researchers have reported the usefulness of needle injection for gene transfer into the skin. To evaluate the transfer efficiency, we compared luciferase activities in the rat skin at 24 h after transfer by the Shima Jet and by a needle (27-gauge). In the rat skin using the Shima Jet, the local expression of luciferase was about 100 times higher than that by a needle, as shown in Figure 2a . Moreover, the effect of gene transfer by the Shima Jet was dose-dependent, as shown in Figure 2a . We also measured gene expression in the skin in sequence after gene transfer by the Shima Jet. Luciferase activity could be observed until 7 days after gene transfer, as shown in Figure 2b . Then, we examined the gene transfer efficiency by measuring human HGF protein level in the skin. Higher expression of human HGF protein was observed in the group transferred by the Shima Jet, as shown in Figure 3 . On the other hand, no expression of human HGF was observed in the group transferred by a needle. Moreover, in the control group transferred with the control plasmid, no human HGF could be detected.
Immunohistochemical analysis of hepatocyte growth factor and prostacyclin synthase
In the first experiment, we confirmed that gene expression of b-galactosidase was observed in the epidermis of the rat skin following transfer by the Shima Jet. Then, we examined whether HGF and PGIS gene expressions are produced in the same manner with the Shima Jet or not. As expected, strong expressions of human HGF and human PGIS were observed in the epidermis of the rat skin around injection sites transferred by the Shima Jet, using antibodies against human HGF and human PGIS, 
Comparison of blood flow by Laser Doppler imaging
The image of the Laser Doppler imaging (LDI) (Moor Instruments, Axminister, UK) analyzer showed that blood flow in the rat skin was not increased apparently on day 4 after transfer with human HGF gene, as shown in Figure 5a . Quantitative analysis also showed no tendency for an increase in blood flow (Figure 5b ). This result does not seem to be consistent with our previous report; 26, 27 however, this assay was performed on day 4 and it seemed too short to induce angiogenesis, indicating that our results of this study are reasonable. On the other hand, additional PGIS gene transfer to HGF gene transfer increased the blood flow even at 4 days (Figure 5a) . A significant increase in the blood flow in PGIS plasmid transferred group compared to other groups was confirmed by quantification ( Figure 5b ).
Comparison of granulation tissue area
There was no significant difference in the granulation tissue area between each group at 3 days after gene transfer ( Figure 6a ). However, there was a tendency for decreasing in groups transferred with HGF gene and co-transferred with HGF and PGIS genes.
Comparison of neovascularization in granulation tissue and cell proliferation in epidermis
The capillary vessels (microvessels) within the granulation tissue were detected by immunohistochemicalstaining for factor VIII. The number of vessels was significantly increased in HGF gene transferred group, and HGF and PGIS genes co-transferred group at 7 days after transfer compared with those in the control group (Figure 6b and c). The number of proliferating cell nuclear antigen (PCNA)-positive cells in the epidermis on the edge of the round wound was significantly increased in HGF gene transferred group at 3 days after gene transfer compared with those in the control group (Po0.05) (Figure 6d and e).
Wound lesion area
The model we used in this study showed natural recovery around 2 weeks after induction of wound, even when we used prednisolone (PZ) (Shionogi Ltd, Osaka, Japan) to induce the wound impairment. Until 7 days, control wounds did not show any decrease in area; so, Human HGF concentration in the skin after transfer of 100 mg/ 100 ml of human HGF gene by a needle and by the Shima Jet is shown. Higher expression of human HGF protein was observed in the group transferred by the Shima Jet. On the other hand, no expression of human HGF was observed in the group transferred by a needle. Moreover, in the control group, no human HGF was detected. ND ¼ not detected; needle ¼ samples from rats transferred by a needle; Shima ¼ samples from rats transferred by the Shima Jet.
Wound healing by HGF and PGIS gene transfer Y Kunugiza et al the effect of gene transfer should be considered until 7 days. On day 0, wound lesion area was taken as 100% in each group. Hepatocyte growth factor gene transfer by the Shima Jet significantly decreased the wound lesion area as compared to the control group at day 6 after gene transfer (Figure 7a and b) . Moreover, even on day 4, a tendency for a decrease but not significant in wound lesion area could be observed in HGF gene transferred group. On the other hand, co-transfer of HGF and PGIS genes showed a significant decrease in wound lesion area as compared to the control group at days 4 and 6 (Po0.05) (Figure 7a and b) , indicating that on both days 4 and 6, additional wound closure effect could be observed by the additional gene transfer of PGIS. Prostacyclin synthase gene transfer alone did not improve the wound closure rate. We also compared the wound closure rate after HGF and PGIS gene transfer by the Shima Jet by a needle. We could not observe a significant wound closure after gene transfer by a needle (Figure 7c ).
Discussion
Wound healing disorders following systemic glucocorticoid treatment are a commonly observed and experimentally proven phenomenon. Glucocorticoid-mediated effects are multifunctional and prevent the early inflammatory phase, which is essential for efficient wound repair, and also intervene in the regulation of proinflammatory cytokines, growth factors, matrix proteins and matrix proteases, which seem to have an impact on wound healing. 28 Glucocorticoid is also known to inhibit angiogenesis and fibroblast proliferation. 29 Topical application of recombinant growth factor proteins has already been used to treat healing wounds. However, this approach has disadvantages, such as the requirement for large amounts of purified recombinant protein, the short half-life of the growth factors owing to proteases at the wound site, the potential toxicities of repeated high doses of growth factors and difficulty with appropriate delivery of growth factors in the wound.
DNA delivery into the skin may be useful for the treatment of skin diseases requiring local or systemic distribution of a transgene product. However, the development of an effective, consistent and patient-friendly transfer system into the skin remains a challenge. The success of gene delivery is largely dependent on the development of methods to deliver genes to target cells with minimal toxic side effects selectively and efficiently. At present, the vast majority of efforts directed toward gene delivery in vivo have focused on viral vectors. Although often effective, viral vectors have significant drawbacks, including concerns about safety, Wound healing by HGF and PGIS gene transfer Y Kunugiza et al scalability of production and cost effectiveness. Nonviral approaches are generally safer and less expensive, but also less effective, and some gene delivery methods need specialized equipment or training for wound treatment. To be able to take full advantage of targeting skin diseases for gene therapy, it is important to establish an efficient and reproducible delivery system.
Jet injection as a tool for gene delivery of plasmid DNA is a strong candidate to meet these criteria. 10 From this point of view, we evaluated the efficiency of intradermal injection of naked plasmid into the skin by a springpowered jet injector, Shima Jet, which was originally developed as a non-needle jet injector of insulin for diabetic patients. Previously, naked DNA has been shown to be delivered and efficiently expressed following direct injection into the skin, without the need for a DNA carrier. In our study, gene expression in the skin was mainly observed in the epidermis. The mechanisms controlling the topical delivery of naked plasmid DNA are poorly understood and need to be further investigated. The advantage of using plasmid DNA alone in gene delivery is that it may avoid potential host responses elicited by viral DNA carriers and that DNA can be repeatedly injected into the desired area to compensate for the loss of gene expression over time. Furthermore, gene transfer efficiency by a Jet injection is higher compared to a needle injection, as reported before in a porcine model. 30 Gene transfer into the skin by the Shima Jet uses naked plasmid without any vectors, is a local therapy, is easy to handle, has high efficiency of transfer and causes little pain. Based on these advantages, gene transfer into the skin by the Shima Jet might have high potential for clinical application. Increased expression of HGF and its receptor, c-met, was observed in response to wounding. 15 Hepatocyte growth factor has a significant effect on vascularization and granulation tissue formation during wound healing in vivo. 31 Moreover, HGF stimulates wound healing, with less susceptibility to cutaneous scarring. 32 In this study, re-epithelialization and microvasculation of the wound were promoted after HGF gene transfer. We measured the expression of human HGF protein in the skin around the wound. Although not measured in this study, the level of rat endogenous HGF may be upregulated after human HGF gene transfer. 3, 33 In the present study, we showed the effectiveness of co-transfer of HGF and PGIS genes by the Shima Jet for wound healing. The process of cutaneous wound healing is characterized by four overlapping repair phases involving hemostasis, inflammation, proliferation and remodeling. After injury, new tissue formation starts with re-epithelialization and is followed by granulation tissue formation. The latter process includes macrophage accumulation, fibroblast growth, matrix deposition and angiogenesis. In our study, by PGIS gene transfer, the blood flow in the skin increased. Prostacyclin has been reported to have a cytoprotective action on endothelial cells and to inhibit VSMC growth. Prostacyclin is an unstable metabolite of arachidonic acid that is produced by endothelial cells and non-enzymatically hydrated. In this study, improvement in wound closure was not detected by PGIS gene transfer alone, which may result from the short half-life of PGI 2 . Previous studies showed that PGI 2 administration in humans induced cutaneous flushing, and intravenous PGI 2 infusion raised skin blood flow as measured by Laser Doppler flowmetry. 34 Thus, PGI 2 is thought to relax the smooth muscle of both large and small arteries, and PGI 2 analogues are widely used for the treatment of peripheral arterial disease. In another study, increased local HGF production from vascular cells by a PGI 2 analogue was suggested Wound healing by HGF and PGIS gene transfer Y Kunugiza et al to improve endothelial dysfunction induced by high glucose, in addition to the direct vasodilator effects on VSMC. 35 Beraprost sodium improves walking distance in patients with peripheral arterial occlusive disease. 36 On the other hand, recently, a beneficial effect of beraprost sodium on rat with anti-glomerular basement membrane serum-induced nephritis was reported. 37 Beraprost sodium has multiple effects directed to improve microcirculation, such as anti-platelet, vasolidator and antiinflammatory effects. 38 Taken together, the present results suggest that blood flow would be increased by vasodilator effect of human PGIS gene transfer, re-epithelialization would be promoted through the regeneration of epithelial cells by human HGF gene transfer, and finally, wound healing would be accelerated by the effects of human HGF and PGIS gene co-transfer in this model. These days, the numbers of patients suffering from incurable ulcers caused by diabetes mellitus or ischemic arterial diseases are increasing. Co-transfer of human HGF and PGIS genes using the Shima Jet as demonstrated in this study would be an ideal and effective strategy for wound healing.
Materials and methods
Construction of plasmids
To produce expression vectors, human HGF cDNA (2.2 kb) 21, 22 or human PGIS cDNA (1.5 kb) 22, 23 was inserted in the PVAX expression vector, which utilizes the cytomegalovirus (CMV) promoter/enhancer. The vector used as control was the CMV vector plasmid, which does not contain HGF or PGIS cDNA. The b-galactosidase gene expression plasmid (pCMV-LacZ) driven by CMV promoter was purchased from a commercial source (Promega Corporation, Madison, WI, USA). The control plasmid for pCMV-LacZ was also purchased from Promega Corporation.
In vivo gene transfer by Shima Jet
This experimental study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of National Institutes of Health (NIH). The protocol was approved by the committee on the Ethics of Animal Experiments in Osaka University. Twelve-week-old female Wister rats were used in this study. All rats were anesthetized intramuscularly with a mixture of xylazine (7 mg/kg) and ketamine (35 mg/kg). The rats' backs were clipped. Naked pCMV-LacZ (100 mg/100 ml/body) or the control plasmid (100 mg/100 ml/body) was transferred into the skin by the Shima Jet. Skin sections were obtained 48 h post-transfer as described previously. 3 Sections were fixed in 1.0% glutaraldehyde in phosphate-buffered saline (PBS) for 5 min, washed three times in PBS and then stained for b-galactosidase activity according to the method described in previous reports. 39 Sections were counterstained with hematoxylin and eosin (HE).
Luciferase activity assay
Luciferase expression plasmid driven by the SV-40 promoter and the control plasmid for luciferase expression plasmid were obtained from a commercial source (Promega Corporation). Rats were killed 1, 3, 7 and 14 days after transfer of luciferase plasmid (50 mg/50 ml/ body or 100 mg/100 ml/body). In this study, we compared the efficiency of gene transfer into the skin by the Shima Jet and by a needle. Moreover, we also compared gene expressions at each time point in the skin after gene transfer by the Shima Jet. Luciferase activity was measured with a luciferase assay system according to the manufacturer's protocol (Promega Corporation).
Measurement of hepatocyte growth factor in skin
Naked human HGF gene (100 mg/100 ml/body) or the control plasmid (100 mg/100 ml/body) was transferred into the skin of rats by the Shima Jet. Tissue samples around injection sites obtained from rats were washed with PBS and homogenized in extraction buffer (20 mM Tris-HCl buffer, pH 7.5, containing 2 M NaCl, 0.1% Tween 80, 1 mM ethylenediamine tetraacetic acid and 1 mM phenylmethyl sulfonyl fluoride) by means of a polytron homogenizer (Kinematica AG, Lucerne, Switzerland). The homogenate was centrifuged at 15 000 r.p.m., at 41C for 30 min, and the resultant supernatant served as the tissue extract. 3 The concentration of HGF in the skin was measured using an enzyme-linked immunosorbent assay kit for human HGF protein (Institute for Immunology, Tokyo, Japan).
Impaired wound healing model
Seven-week-old male Wister rats weighing 200-250 g were used to make this model. We used 30 rats and divided them into five groups (six rats for each group). The impaired wound healing rat model was made as described previously. 40 Briefly, PZ suspended in PBS was intramuscularly (i.m.) injected twice (3 days and immediately before the wounding) at a dose of 30 mg/kg with a needle to rats of groups two, three, four and five, and PBS instead of PZ was injected into rats of group 1 as control. The rats' backs were clipped and depilated with Epilat (Kanebo, Tokyo, Japan). One full-thickness wound (1.6 cm in diameter) was made on the back of each rat. To measure the wound closure, the wound was traced on tracing paper and the traced area was calculated by NIH imaging software on days 0, 4, 6 and 12 (National Institutes of Health, Bethesda, MD, USA). Local transfer of hepatocyte growth factor and prostacyclin synthase genes into rat skin On day 0, the same day of making the wound, human HGF gene (100 mg, five points) and human PGIS gene (100 mg, five points) were transferred around the wound by the Shima Jet. Human HGF gene was transferred to rats of group 3 (PZ/HGF), PGIS gene was transferred to rats of group 4 (PZ/PGIS), both genes were transferred to rats of group 5 (PZ/HGF+PGIS) and PBS instead of functional genes was injected into rats of groups 1 (PBS/ PBS) and 2 (PZ/PBS). As an additional experiment, the same amount of HGF gene and PGIS gene was transferred around the wound by a needle.
Measurement of blood flow by Laser Doppler imaging
Measurement of blood flow with LDI (Moor Instruments) was performed as described previously. 26, 27 Because Laser Doppler flow velocity correlates with capillary density, we measured skin blood flow by LDI. Consecutive measurements were obtained over the same regions of interest by averaging four sites around the wound.
Immunohistochemical analysis of hepatocyte growth factor, prostacyclin synthase and proliferating cell nuclear antigen For immunohistochemistry, skin samples were fixed with 4% paraformaldehyde, and deparaffinized and sectioned. To analyze the localization and expression of human HGF, factor VIII and PCNA tissue samples were incubated with a rabbit polyclonal antibody against human HGF (diluted 1:10; Institute of Immunology), human factor VIII (diluted 1:400; Sigma-Aldrich, St Louis, MO, USA), mouse monoclonal antibodies against PCNA (PC-10, 1:50; Dako Inc., Kyoto, Japan) and biotinylated secondary antibody against rabbit and mouse immunoglobulin (Vectastatin Elite ABC kit) (Vectastatin, Burlingame, CA, USA). The rabbit polyclonal antibody against human HGF specifically crossreacts only with human HGF but not with rat HGF. [16] [17] [18] To analyze the localization and expression of human PGIS, skin samples were snap frozen in liquid nitrogen and sectioned. Skin sections were fixed in acetone and incubated with a mixture of rabbit polyclonal antibody against human PGIS (1:1000) and biotinylated goat polyclonal secondary antibody against rabbit immunoglobulin (1:300) (Dako Inc.). Then, sections were incubated with peroxidase-conjugated streptavidin (Dako Inc.).
Measurement of granulation tissue area
After HE staining of sections obtained from the wound, granulation tissue area was measured as an index of wound contraction. The area of granulation tissue was 
Statistical analysis
The results are expressed as the mean7s.e.m. Fisher's protected least-significant difference test was applied to the data when significant F ratios were obtained in analysis of variance. Differences are considered to be significant at Po0.05.
